Related Experiment Video
Updated: Jan 4, 2026
06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
1.5K
[Severe bleeding with antiplatelet therapy: What to do?]
Guillaume Cayla1, Luc Cornillet1, Bertrand Ledermann1
1Université de Montpellier, CHU de Nîmes, service de cardiologie, 30029 Nîmes, France.
Presse Medicale (Paris, France : 1983)
|November 5, 2019
Summary
Dual antiplatelet therapy, combining aspirin and a P2Y12 inhibitor, is crucial for coronary artery disease. Managing bleeding complications requires careful risk assessment and often involves stopping dual antiplatelet therapy.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Dual antiplatelet therapy (DAPT) is standard for acute coronary syndrome and following percutaneous coronary intervention.
- Aspirin and P2Y12 inhibitors are key components of DAPT.
- Bleeding is the most common complication, ranging from minimal to severe.
Purpose of the Study:
- To review the management of bleeding complications in patients on dual antiplatelet therapy.
- To emphasize the importance of individualized risk assessment for DAPT duration.
Main Methods:
- Literature review on antiplatelet therapy in coronary artery disease.
- Analysis of current guidelines for managing bleeding complications.
Main Results:
- Optimal DAPT duration is determined by patient-specific ischemic and bleeding risks.
- Severe bleeding necessitates interruption of DAPT in most cases.
- Individualized bleeding risk assessment is critical.
Conclusions:
- Effective management of bleeding complications is essential for patient safety.
- DAPT interruption is frequently required for severe bleeding events.
- Balancing ischemic protection and bleeding risk is paramount in DAPT management.
Related Concept Videos
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.0K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.0K
01:22Formation of the Platelet Plug
8.5K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.5K
01:29Venous Thrombosis III: Interprofessional Care
247
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
247
01:30Venous Thrombosis IV: Nursing Management
169
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
169
01:28Esophageal Varices-II: Clinical Features and Management
331
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
331
01:27Peripheral Artery Disease III: Interprofessional Care
210
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
210